CVKD

Cadrenal Therapeutics, Inc.

Healthcare · Biotechnology

$253.39 sample

+3.73 (+1.49%) 1D

Market cap

$494.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-12

Alerts

8

Price$253.39 +9.97% 3M daily closessample

253.39225.12

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12SEC8-K filed: material event
Oct 07INSInsider buy: Chief Executive Officer
Sep 29INSInsider buy: EVP, Operations
Sep 23INSInsider sell: Chief Executive Officer
Sep 16INSInsider sell: Chief Executive Officer
Sep 10SEC8-K filed: material event
Sep 03INSInsider sell: Chief Executive Officer
Aug 28SECForm 144 filed

Sign up to see the real CVKD record →

Company facts

SEC EDGAR registration

Name: Cadrenal Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -49sample, -100 to +100
Reporting currency: USD

Who is positioning in CVKD

sample

Insiders: 18 insider transactions over 90 days, net selling, $365.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 15 funds hold $10.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$31.3B +14.9% y/y

Q4 2024Q3 2026

Inventory$18.7B +9.5% y/y

Q4 2024Q3 2026

Accounts receivable$13.2B +5.9% y/y

Q4 2024Q3 2026

Total debt$38.1B +20.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $408.8B -12.1% 3M
Sample peer B: $265.2B -10.4% 3M
Sample peer C: $338.6B +0.7% 3M
Sample peer D: $342.8B -8.5% 3M
Sample peer E: $440.5B -10.9% 3M